≥99% HPLCPre-filled pen

Kisspeptin

Name: Kisspeptin
Brand: Dripfy
Availability: InStock

What it is?

Kisspeptin is a naturally occurring peptide central to reproductive hormone regulation, studied for its role in initiating and modulating the HPG axis. It is positioned for protocols targeting GnRH signalling, downstream gonadotropin dynamics, and hormone-balance endpoints relevant to libido and fertility research.

Dripfy Advantage

Hypothalamic axis activation: Stimulates GnRH release in the hypothalamus, initiating upstream control of reproductive hormone signalling.
Gonadotropin modulation: Associated with increased LH and FSH signalling, supporting downstream endocrine endpoints.
Neuroendocrine integration: Connects central neuro-signalling with peripheral hormone production—useful in protocols studying libido and hormone interplay.
Reproductive-axis precision: Often positioned as a pathway-specific tool for studying hormonal regulation without broad, non-specific endocrine stimulation.

Clinical Applications & Therapeutic Potential

Reproductive hormone balance: Potential support for normalisation of GnRH–LH/FSH axis markers in selected endocrine profiles.
Testosterone-related endpoints (male contexts): Potential support for testosterone production markers via HPG-axis activation (context-dependent).
Fertility research frameworks: Positioned for fertility-related endpoints and reproductive hormone coordination markers in appropriate models.
Libido and performance signalling: Potential support for desire and performance endpoints where dysregulation is linked to neuroendocrine signalling factors.

Composition & Formulation

Peptide: Kisspeptin (KISS1/KISS1R axis)
Format: Ready-to-use pre-filled pen

€374

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Pre-filled pen
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

Kisspeptin

Reproductive neuropeptide (KISS1R agonist, HPG-axis) · Pre-filled pen

C· Emerging evidence

Kisspeptin acts high in the reproductive control system by stimulating the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus. This in turn prompts the pituitary to release luteinising hormone (LH) and follicle-stimulating hormone (FSH), the gonadotropins that regulate sex-hormone production. Because it sits at the top of the hypothalamic–pituitary–gonadal (HPG) axis, it is studied as a precise tool for probing desire and reproductive signalling.

Studied use areas

Research on hypothalamic–pituitary–gonadal (HPG) axis regulation
Investigation of GnRH, LH and FSH signalling dynamics
Study of sexual desire and central arousal in relation to reproductive hormones
Fertility- and reproductive-hormone-balance research contexts

Safety & status

Prescription-only / clinical-research domain in the EU/UK; not an over-the-counter compound
Investigational for libido and sexual health — not an approved treatment for these uses
Human safety data are still limited and largely confined to controlled studies
Any use requires physician supervision with appropriate endocrine screening and monitoring

⚕ Clinical note: This information is educational only and is not medical advice or a promise of any result. Kisspeptin is investigational and sits within the prescription and clinical-research domain; it should only ever be considered under the supervision of a qualified physician.

Evidence: Grade C — investigational; active human research on reproductive-hormone signalling but no marketing authorisation for libido or sexual-health use. · References: Peer-reviewed reproductive-endocrinology and neuroendocrinology literature; Clinical research on kisspeptin and gonadotropin (LH/FSH) regulation; Academic reviews of the HPG axis and GnRH signalling